p53-targeted cancer pharmacotherapy: move towards small molecule compounds
Objectives For the past three decades of research, p53 has been identified as one of the most targetable molecules for developing anticancer treatments. This tumour suppressor protein is involved in apoptosis, cell cycle arrest and senescence. A wide range of pharmaceutical drugs and radiotherapy tr...
| Main Authors: | , |
|---|---|
| Format: | Journal Article |
| Published: |
John Wiley & Sons Ltd.
2011
|
| Online Access: | http://hdl.handle.net/20.500.11937/14671 |